Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.95B |
| 2 |
Digital Realty Trust
DLR
|
+$1.42B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.36B |
| 4 |
Canadian Natural Resources
CNQ
|
+$966M |
| 5 |
US Bancorp
USB
|
+$658M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.4B |
| 2 |
Gilead Sciences
GILD
|
+$2.3B |
| 3 |
Biogen
BIIB
|
+$1.75B |
| 4 |
Goldman Sachs
GS
|
+$1.15B |
| 5 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$1.12B |
Sector Composition
| 1 | Healthcare | 21.03% |
| 2 | Technology | 12.36% |
| 3 | Industrials | 11.39% |
| 4 | Communication Services | 10.61% |
| 5 | Consumer Staples | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Vale
VALE
$45.5B
| $220M | 0.07% |
26,875,000
+22,250,566
| +481% | +$182M |
|
227
Scotiabank
BNS
$78.7B
| $220M | 0.07% |
4,064,899
-39,665
| -1% | -$2.14M |
|
|
SIVB
228
DELISTED
SVB Financial Group
SIVB
| $214M | 0.07% |
1,843,800
| – | – |
|
229
PACCAR
PCAR
$53.8B
| $213M | 0.07% |
4,702,350
-2,617,500
| -36% | -$119M |
|
230
John Wiley & Sons Class A
WLY
$2.19B
| $204M | 0.07% |
3,435,683
-85,000
| -2% | -$5.04M |
|
|
NUVA
231
DELISTED
NuVasive, Inc.
NUVA
| $200M | 0.07% |
4,243,036
| – | – |
|
232
HDFC Bank
HDB
$179B
| $200M | 0.07% |
7,883,000
| – | – |
|
233
McDonald's
MCD
$218B
| $197M | 0.07% |
2,100,000
+300,000
| +17% | +$28.1M |
|
234
Rockwell Automation
ROK
$38.8B
| $195M | 0.07% |
1,754,200
-123,482
| -7% | -$13.7M |
|
235
Grifois
GRFS
$6.72B
| $188M | 0.06% |
11,069,972
+339,040
| +3% | +$5.76M |
|
|
ACC
236
DELISTED
American Campus Communities, Inc.
ACC
| $187M | 0.06% |
+4,527,712
| New | +$187M |
|
237
Travel + Leisure Co
TNL
$4.02B
| $186M | 0.06% |
+4,810,818
| New | +$186M |
|
238
HSBC
HSBC
$238B
| $182M | 0.06% |
4,466,039
| – | – |
|
239
Bristol-Myers Squibb
BMY
$94B
| $179M | 0.06% |
3,025,000
| – | – |
|
240
Sherwin-Williams
SHW
$89.8B
| $174M | 0.06% |
1,980,000
| – | – |
|
241
JB Hunt Transport Services
JBHT
$13.4B
| $173M | 0.06% |
2,055,519
| – | – |
|
242
Landstar System
LSTR
$4.46B
| $172M | 0.06% |
2,377,600
-280,000
| -11% | -$20.3M |
|
243
Exact Sciences
EXAS
$10.2B
| $172M | 0.06% |
6,270,251
+1,441,037
| +30% | +$39.5M |
|
244
Ultragenyx Pharmaceutical
RARE
$2.92B
| $171M | 0.06% |
3,907,586
+81,310
| +2% | +$3.57M |
|
|
FLG
245
Flagstar Financial, Inc.
FLG
$5.27B
| $171M | 0.06% |
3,554,000
| – | – |
|
246
Kohl's
KSS
$1.71B
| $171M | 0.06% |
2,794,000
| – | – |
|
247
D.R. Horton
DHI
$53B
| $169M | 0.06% |
6,685,000
| – | – |
|
248
Weyerhaeuser
WY
$18B
| $169M | 0.06% |
4,706,862
-3,359,686
| -42% | -$121M |
|
|
EXCU
249
DELISTED
Exelon Corporation
EXCU
| $168M | 0.06% |
3,200,000
| – | – |
|
250
BP
BP
$87.3B
| $167M | 0.06% |
5,293,673
+778,195
| +17% | +$24.6M |
|